Margoni M - Search Results

1

The ageing central nervous system in multiple sclerosis: the imaging perspective.

Filippi M, Preziosa P, Barkhof F, Ciccarelli O, Cossarizza A, De Stefano N, Gasperini C, Geraldes R, Granziera C, Haider L, Lassmann H, Margoni M, Pontillo G, Ropele S, Rovira À, Sastre-Garriga J, Yousry TA, Rocca MA. Filippi M, et al. Among authors: margoni m. Brain. 2024 Nov 4;147(11):3665-3680. doi: 10.1093/brain/awae251. Brain. 2024. PMID: 39045667 Free PMC article. Review.

2

Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques.

Petracca M, Margoni M, Bommarito G, Inglese M. Petracca M, et al. Among authors: margoni m. Neurol Ther. 2018 Dec;7(2):265-285. doi: 10.1007/s40120-018-0103-2. Epub 2018 Jun 28. Neurol Ther. 2018. PMID: 29956263 Free PMC article. Review.

3

No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab.

Margoni M, Rinaldi F, Riccardi A, Franciotta S, Perini P, Gallo P. Margoni M, et al. J Neurol. 2020 Jan;267(1):100-105. doi: 10.1007/s00415-019-09554-z. Epub 2019 Sep 27. J Neurol. 2020. PMID: 31562558

4

Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset.

Margoni M, Franciotta S, Poggiali D, Riccardi A, Rinaldi F, Nosadini M, Sartori S, Anglani MG, Causin F, Perini P, Gallo P. Margoni M, et al. J Neurol. 2020 Jun;267(6):1824-1829. doi: 10.1007/s00415-020-09776-6. Epub 2020 Mar 5. J Neurol. 2020. PMID: 32140864

5

Early red nucleus atrophy in relapse-onset multiple sclerosis.

Margoni M, Poggiali D, Zywicki S, Rubin M, Lazzarotto A, Franciotta S, Anglani MG, Causin F, Rinaldi F, Perini P, Filippi M, Gallo P. Margoni M, et al. Hum Brain Mapp. 2021 Jan;42(1):154-160. doi: 10.1002/hbm.25213. Epub 2020 Oct 13. Hum Brain Mapp. 2021. PMID: 33047810 Free PMC article.

6

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities.

Margoni M, Rinaldi F, Perini P, Gallo P. Margoni M, et al. Front Neurol. 2021 May 17;12:676095. doi: 10.3389/fneur.2021.676095. eCollection 2021. Front Neurol. 2021. PMID: 34079516 Free PMC article. Review.

7

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives.

Margoni M, Preziosa P, Filippi M, Rocca MA. Margoni M, et al. J Neurol. 2022 Mar;269(3):1316-1334. doi: 10.1007/s00415-021-10744-x. Epub 2021 Aug 11. J Neurol. 2022. PMID: 34382120 Free PMC article. Review.

8

Pediatric multiple sclerosis: developments in timely diagnosis and prognostication.

Margoni M, Preziosa P, Rocca MA, Filippi M. Margoni M, et al. Expert Rev Neurother. 2022 May;22(5):393-403. doi: 10.1080/14737175.2022.2064743. Epub 2022 Apr 13. Expert Rev Neurother. 2022. PMID: 35400266 Review.

9

Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study.

Margoni M, Pagani E, Meani A, Storelli L, Mesaros S, Drulovic J, Barkhof F, Vrenken H, Strijbis E, Gallo A, Bisecco A, Pareto D, Sastre-Garriga J, Ciccarelli O, Yiannakas M, Palace J, Preziosa P, Rocca MA, Filippi M; MAGNIMS Study Group. Margoni M, et al. J Neurol Neurosurg Psychiatry. 2022 Jul;93(7):741-752. doi: 10.1136/jnnp-2022-328908. Epub 2022 May 17. J Neurol Neurosurg Psychiatry. 2022. PMID: 35580993

10

Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers.

Margoni M, Preziosa P, Tortorella P, Filippi M, Rocca MA. Margoni M, et al. Neurotherapeutics. 2022 Jul;19(4):1216-1228. doi: 10.1007/s13311-022-01252-5. Epub 2022 Jun 6. Neurotherapeutics. 2022. PMID: 35668317 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters